Leads a high performing Respiratory Product Strategy Team (RPST) comprised of cross-functional leaders accountable for setting the strategy for the late stage respiratory programs
Direct management and development of medical monitors and clinical scientists
Develops high quality, ambitious development plans for asthma and COPD programs, aligned with late-stage and corporate objectives and compliant with all relevant regulations
Recruits, mentors and manages late-state clinicians and scientists
Collaborates with Head of Safety and PV to define risk-benefit profiles
Collaborates with Clinical operations and CRO to deliver study to timelines and budget
Oversees protocol development and clinical/scientific content for regulatory submissions and interactions
Provides medical leadership and awareness of evolving external landscape for late-stage clinical trials in respiratory diseases (asthma, COPD)
Drives development and refinement of Target Product Profiles (TPPs), Target Product Claims,and clinical development strategies
Oversee protocol development, study design, medical review of data, and safety monitoring
Serve as the primary medical contact for clinical sites, investigators, and regulatory bodies
Guide interactions with external stakeholders including KOLs, advisory boards, and CROs
Represent Generate externally at scientific, medical, and regulatory meetings

MD or PhD required, board certification in Pulmonology or Allergy and Immunology Medicine preferred
10+ years of clinical development experience in the biopharma industry
Deep expertise in respiratory diseases (asthma, COPD) and late-stage clinical trials
Demonstrated success in leading pivotal global studies and regulatory interactions
Strong analytical, communication, and cross-functional leadership skills
Proven ability to influence internal and external stakeholders, including investigators and health authorities.

Vice President, Global Respiratory Products Leader

Key skills